S, T., H, S., & S, K. (2022). Treatments for skeletal muscle abnormalities in heart failure: Sodium-glucose transporter 2 and ketone bodies. American journal of physiology. Heart and circulatory physiology, 322(2), H117. https://doi.org/10.1152/ajpheart.00100.2021
Chicago Style (17th ed.) CitationS, Takada, Sabe H, and Kinugawa S. "Treatments for Skeletal Muscle Abnormalities in Heart Failure: Sodium-glucose Transporter 2 and Ketone Bodies." American Journal of Physiology. Heart and Circulatory Physiology 322, no. 2 (2022): H117. https://doi.org/10.1152/ajpheart.00100.2021.
MLA (9th ed.) CitationS, Takada, et al. "Treatments for Skeletal Muscle Abnormalities in Heart Failure: Sodium-glucose Transporter 2 and Ketone Bodies." American Journal of Physiology. Heart and Circulatory Physiology, vol. 322, no. 2, 2022, p. H117, https://doi.org/10.1152/ajpheart.00100.2021.